Back
ESC Premium Access

Drug-testing using human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome

Session: Poster Session 3 - Arrhythmia mechanisms - General
Topic: Antiarrhythmic Drug Treatment
Speaker: Mrs Z. Zhao (Mannheim, DE)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Mrs Zhihan Zhao

University Medical Centre of Mannheim, Mannheim (Germany)
0 follower

10 more presentations in this session

Sudden cardiac arrest in patients without overt heart disease - Clinical assessment, family screening and genetic testing by next generation sequencing.

Speaker: Doctor M. Stepien-Wojno (Warsaw, PL)

Access
Abstract
Like
Thumbnail

Validation of the indication for implantable cardioverter defibrillator in Brugada syndrome in the J Wave Syndromes Consensus Conference

Speaker: Professor M. Takagi (Moriguchi, JP)

Access
Abstract
Like
Thumbnail

GENECHOC study: a study designed to identify the genetic variants involved in appropriate shock in primary prevention; clinical description of the patients

Speaker: Professor V. Probst (Nantes, FR)

Access
Abstract
Like
Thumbnail

Late gadolinium enhancement at cardiac magnetic resonance accurately predicts arrhythmias in patients with non-ischemic cardiomyopathy

Speaker: Doctor C. Raineri (Turin, IT)

Access
Abstract
Like
Thumbnail

Ranolazine reduces levosimendan-mediated atrial fibrillation in an experimental whole-heart model

Speaker: Professor G. Frommeyer (Munster, DE)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Arrhythmia mechanisms - General

Speakers: Mrs Z. Zhao, Doctor M. Stepien-Wojno, Professor M. Takagi, Professor V. Probst, Doctor C. Raineri...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources